Aikido pharma inc. (SPEX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues

-

-

-

-

-

-

-

-

-

1,236

1,266

1,266

1,132

877

0

0

0

-

-

-

8

10

28

28

25

27

11

26

26

20

0

0

0

-

-

1,188

0

0

0

Operating costs and expenses
Amortization of patent portfolio

-

-

-

-

-

1,405

1,373

1,373

1,373

1,373

1,564

1,754

1,942

2,135

0

0

0

-

-

-

9,825

9,831

7,486

5,144

2,695

267

0

0

0

-

-

-

-

-

-

-

-

-

-

Rent

-

-

-

-

-

-

-

-

-

92

89

88

84

84

87

89

88

88

721

770

819

864

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Depreciation expense

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

24

24

0

0

-

0

-

-

-

-

-

-

-

-

Acquisition costs

-

-

-

96

-

-

-

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

3,762

3,172

4,216

3,878

3,895

3,324

932

515

573

493

438

366

252

253

0

0

0

-

-

-

1,086

1,696

-1,907

790

1,400

1,010

2,725

478

348

595

2,278

2,153

2,308

2,548

2,968

3,781

0

0

0

Amortization of patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Compensation and related expenses (including stock-based compensation)

-

-

-

671

-

-

-

1,873

1,825

2,059

1,812

2,160

2,227

1,950

0

0

0

-

-

-

10,897

13,710

15,187

19,781

12,860

9,783

7,129

0

0

-

0

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of patent portfolio

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Compensation and related expenses (including stock-based compensation)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

Direct costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Research and development

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,132

1,395

1,661

1,645

2,585

3,758

0

0

0

Research and development - license acquired

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development - license acquired

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Professional fees

-

-

-

1,524

-

-

-

1,495

1,350

1,038

1,236

1,299

1,873

2,293

2,585

3,029

2,756

2,780

2,895

2,834

4,099

4,520

0

0

0

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

7,380

5,694

4,615

5,664

6,038

6,902

6,191

5,513

5,339

5,058

7,853

8,380

9,091

9,428

10,895

11,054

49,558

52,043

52,235

55,440

26,726

30,621

28,957

33,112

22,470

15,374

12,291

3,623

3,345

3,492

3,161

3,299

3,839

4,193

5,924

8,023

0

0

0

Loss from operations

-7,371

-5,685

-4,587

-5,636

-6,010

-6,874

-5,907

-4,915

-4,430

-3,822

-6,587

-7,114

-7,959

-8,551

-10,301

-10,774

-49,455

-52,010

-52,232

-55,435

-26,718

-30,611

-28,929

-33,084

-22,445

-15,347

-12,280

-3,597

-3,319

-3,472

-3,637

-3,792

-4,146

-4,193

-5,063

-6,835

0

0

0

Other expenses
Gains and (losses) on marketable securities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expenses), net

-

-

-77

-79

-

-333

-233

-192

22

291

76

86

20

-182

0

0

0

-

-

-

0

-

-

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of investment

-3,190

1,406

-2,085

350

0

-

-

0

-

-

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

-

-82

-261

-349

-499

-740

-699

-1,671

-190

120

57

100

-593

-2,257

0

0

0

-

-

-

0

-

0

0

-

2,618

0

0

0

-

-

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expenses

-3,996

1,502

4,933

7,454

8,074

8,601

1,146

2,504

557

516

364

-14

613

2,075

3,383

1,576

2,027

545

-745

40

63

79

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

Unrealized (loss) gain on the change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

3

3

3

3

5

0

0

0

Fair value adjustments for warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

Loss from continuing operations before taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51

0

0

0

-

-

Gain on settlement of obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-845

0

0

0

-

-

(Loss) income from continuing operations before taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

417

-4,162

-5,931

0

0

0

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,888

0

0

0

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Loss from discontinued operations before taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-448

0

0

-

0

-

-

-

-

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-14

-14

-14

0

0

0

0

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-969

-448

0

0

-

0

-

-

-

-

Net loss

-11,367

-4,183

346

1,818

2,064

1,727

-4,761

-2,411

-3,873

-3,306

-6,223

-7,128

-7,346

-6,476

-6,918

-9,198

-47,428

-51,465

-52,977

-55,395

-26,655

-30,532

-28,856

-32,992

-22,231

-17,965

-15,694

-7,122

-6,719

-3,857

0

0

0

-

-

-

-

-

-

Deemed capital contribution on extinguishment of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-31,480

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed capital contribution on extinguishment of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

25,004

33,057

30,777

-38,933

-42,303

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,301

0

0

0

-

Net loss per share, basic and diluted
Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6.15

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.98

-

-

-

-

Basic and Diluted

-0.91

-

-1.38

-

-0.57

-

-0.94

-

-0.96

-

-

-0.38

-0.19

-

-

-

-0.26

-

-

-

-2.71

-26.88

-0.18

-0.69

-1.66

-0.22

-6.93

-1.14

-5.35

-

-

-

-

-

-7.13

-

-

-

-

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

9.61

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2.76

-1.56

-3.89

-

-

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.64

-0.38

-0.59

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Basic

-

-

-

-0.30

-

-

-

-0.20

-

-

0.08

-

-

-

-

-

-

-

-1.56

-26.76

-

-

-

-

-

-

-

-

-

-

-3.40

-1.95

-4.48

-

-

-0.40

-0.10

-1.25

-1.49

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

9.21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

-

-

-

-0.30

-

-

-

-0.20

-

-

0.08

-

-

-

-

-

-

-

-1.56

-26.76

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.40

-0.10

-1.25

-1.49

Weighted average number of shares outstanding, basic and diluted
Basic and Diluted

9,195

-

2,442

-

2,010

-

2,010

-

1,549

-

-

4,958

4,943

-

-

-

2,705

-

-

-

1,505

-45,581

28,065

16,879

4,789

2,533

1,339

705

691

-

-

-

-

-

128

-

-

-

-

Basic

-

-

-

2,124

-

-

-

2,008

-

-

5,998

-

-

-

4,163

3,060

-

-

1,744

1,506

-

-

-

-

-

-

-

-

-

-

207

207

186

-

-

2,562

2,448

1,715

1,715

Diluted

-

-

-

2,124

-

-

-

2,008

-

-

6,009

-

-

-

4,163

3,193

-

-

1,744

1,506

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,562

2,448

1,715

1,715